Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1983 May;15(5):557–559. doi: 10.1111/j.1365-2125.1983.tb02090.x

Dystonic reactions and the pharmacokinetics of metoclopramide in children.

D N Bateman, A W Craft, E Nicholson, A D Pearson
PMCID: PMC1427723  PMID: 6860530

Abstract

The pharmacokinetics of metoclopramide have been studied in nine children receiving the drug as prophylaxis for cytotoxic induced vomiting. Plasma concentrations of metoclopramide have also been studied in three children with dystonic reactions to the drug. The pharmacokinetics in children were similar to those reported in healthy adults. There was no difference in the plasma concentration of metoclopramide of children with dystonia when compared to those without this adverse effect. Kinetic differences in childhood do not explain the occurrence of dystonia, which in the individual appears to be related to factors other than plasma drug concentrations.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bateman D. N., Blain P. G. Dopamine-receptor blockade and tardive dyskinesia. Lancet. 1979 Sep 22;2(8143):641–641. doi: 10.1016/s0140-6736(79)91704-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bateman D. N., Gokal R., Dodd T. R., Blain P. G. The pharmacokinetics of single doses of metoclopramide in renal failure. Eur J Clin Pharmacol. 1981;19(6):437–441. doi: 10.1007/BF00548588. [DOI] [PubMed] [Google Scholar]
  3. Bateman D. N., Kahn C., Davies D. S. Concentration effect studies with oral metoclopramide. Br J Clin Pharmacol. 1979 Aug;8(2):179–182. doi: 10.1111/j.1365-2125.1979.tb05818.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bateman D. N., Kahn C., Mashiter K., Davies D. S. Pharmacokinetic and concentration-effect studies with intravenous metoclopramide. Br J Clin Pharmacol. 1978 Nov;6(5):401–407. doi: 10.1111/j.1365-2125.1978.tb04604.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Casteels-Van Daele M., Jaeken J., Van der Schueren P., Van den Bon P. Dystonic reactions in children caused by metoclopramide. Arch Dis Child. 1970 Feb;45(239):130–133. doi: 10.1136/adc.45.239.130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Garver D. L., Davis D. M., Dekirmenjian H., Ericksen S., Gosenfeld L., Haraszti J. Dystonic reactions following neuroleptics: time course and proposed mechanisms. Psychopharmacologia. 1976 May 28;47(2):199–201. doi: 10.1007/BF00735822. [DOI] [PubMed] [Google Scholar]
  7. Garver D. L., Davis J. M., Dekirmenjian H., Jones F. D., Casper R., Haraszti J. Pharmacokinetics of red blood cell phenothiazine and clinical effects. Acute dystonic reactions. Arch Gen Psychiatry. 1976 Jul;33(7):862–866. doi: 10.1001/archpsyc.1976.01770070092011. [DOI] [PubMed] [Google Scholar]
  8. Graffner C., Lagerström P. O., Lundborg P., Rönn O. Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography. Br J Clin Pharmacol. 1979 Nov;8(5):469–474. doi: 10.1111/j.1365-2125.1979.tb01028.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lavy S., Melamed E., Penchas S. Tardive dyskinesia associated with metoclopramide. Br Med J. 1978 Jan 14;1(6105):77–78. doi: 10.1136/bmj.1.6105.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Tam Y. K., Axelson J. E., McErlane B., Ongley R., Price J. D. Dose-dependent pharmacokinetics of metoclopramide in rat: an effect of hemoperfusion? J Pharmacol Exp Ther. 1981 Jun;217(3):764–769. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES